Myriad Genetics, Inc. recently announced that Janssen Research & Development, LLC

Login
Username

Password

Remember Me
/
Create an account

Name: (*)

Username: (*)

Password: (*)

Confirm Password: (*)

Email: (*)

Confirm email Address: (*)

Captcha: (*)

Fields marked with an asterisk (*) are required.

DERMASCOPE The authority on professional skin care

Myriad Genetics, Inc. recently announced that Janssen Research & Development, LLC

Written by Jeremy Lawrence

font size decrease font size increase font size
Print
Email

Myriad Genetics, Inc. recently announced that Janssen Research & Development, LLC, will use Myriad’s BRACAnalysis test in connection with its Phase 3 clinical trial of Yondelis® (trabectedin) in the treatment of advanced-relapsed epithelial ovarian, primary peritoneal or fallopian tube cancers.